Eye Diseases Completed Phase 1 Trials for Brimonidine (DB00484)

IndicationStatusPhase
DBCOND0030511 (Eye Diseases)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02967614KJ-TFC-004 Drug-drug Interaction StudyTreatment